| scholarly article | Q13442814 |
| P50 | author | Friedemann Paul | Q30353016 |
| Stefan Gold | Q40302770 | ||
| P2093 | author name string | Michael Levy | |
| Alexander Ulrich Brandt | |||
| Florence Pache | |||
| Klemens Ruprecht | |||
| Maureen A Mealy | |||
| Alexandra Simpson | |||
| Anna Lacheta | |||
| Velina S Chavarro | |||
| P2860 | cites work | Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients | Q21093230 |
| Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder | Q21094858 | ||
| What do we know about brain contrast enhancement patterns in neuromyelitis optica? | Q26776278 | ||
| Aquaporin-4 autoimmunity | Q26799559 | ||
| International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Q26824579 | ||
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update | Q28087067 | ||
| Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation | Q28307938 | ||
| Neuromyelitis optica: clinical features, immunopathogenesis and treatment. | Q30785267 | ||
| Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients | Q34413083 | ||
| Treatment of neuropathic pain: an overview of recent guidelines | Q35006269 | ||
| Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). | Q35052199 | ||
| Demographic and clinical features of neuromyelitis optica: A review. | Q35718428 | ||
| Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer | Q35946004 | ||
| Major depressive disorder: new clinical, neurobiological, and treatment perspectives | Q36096664 | ||
| Association of neuromyelitis optica with severe and intractable pain. | Q36579382 | ||
| Treatment of Neuromyelitis Optica: Review and Recommendations. | Q37588037 | ||
| Epidemiology of neuromyelitis optica in the United States: a multicenter analysis | Q38021662 | ||
| Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Q38337465 | ||
| Cognitive and psychiatric comorbidities in neuromyelitis optica | Q40151981 | ||
| Chronic pain-associated depression: antecedent or consequence of chronic pain? A review | Q41499997 | ||
| Hopelessness, depression, suicidal ideation, and clinical diagnosis of depression. | Q47353041 | ||
| The relationship between pain and depression | Q47631756 | ||
| Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life | Q48086806 | ||
| Cognitive and affective assessments of multiple sclerosis (MS) and neuromyelitis optica (NMO) patients utilizing computerized touch panel-type screening tests | Q48191054 | ||
| painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain | Q48488749 | ||
| Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica. | Q48755526 | ||
| Fatigue, mood and quality of life improve in MS patients after progressive resistance training | Q48873478 | ||
| Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. | Q50966511 | ||
| Diagnosis and treatment of depression comorbid with neurologic disorders. | Q51876854 | ||
| Validation of the Brief Pain Inventory for chronic nonmalignant pain. | Q51942165 | ||
| Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. | Q51951778 | ||
| Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. | Q51967528 | ||
| Fatigue, depression and quality of life in cancer patients: how are they related? | Q53580527 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases | Q71113207 | ||
| Fatigue in multiple sclerosis and its relationship to depression and neurologic disability | Q73934732 | ||
| Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics | Q83802967 | ||
| P433 | issue | 6 | |
| P921 | main subject | neuromyelitis optica | Q611458 |
| P304 | page(s) | e286 | |
| P577 | publication date | 2016-10-24 | |
| P1433 | published in | Neurology(R) neuroimmunology & neuroinflammation | Q27725776 |
| P1476 | title | Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder | |
| P478 | volume | 3 |
| Q64963331 | Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features. |
| Q92244089 | Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD |
| Q90372148 | Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica |
| Q47104784 | Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations |
| Q60921343 | Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico |
| Q57492183 | Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence |
| Q58573155 | Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis |
| Q91596108 | Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis |
| Q42361527 | Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system. |
| Q50063088 | Fatigue as a symptom or comorbidity of neurological diseases |
| Q33719007 | Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life |
| Q30235347 | Headache in Neuromyelitis Optica |
| Q90102211 | Headache in the course of multiple sclerosis: a prospective study |
| Q99585316 | Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study |
| Q90559483 | Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions |
| Q37661860 | Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. |
| Q41503702 | Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder |
| Q92244063 | Neuromyelitis optica spectrum disorder: Patient experience and quality of life |
| Q64075567 | Neuromyelitis optica spectrum disorders |
| Q36218541 | Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis |
| Q50101454 | Optical coherence tomography in neuromyelitis optica spectrum disorders |
| Q52668258 | Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy. |
| Q64969422 | Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders. |
| Q58563707 | Sex differences in autoimmune disorders of the central nervous system |
| Q37709549 | Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone-risperidone combination: a case report |
| Q97067402 | Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders |
| Q47163794 | Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases. |
Search more.